MD, Medicine
PhD, Medicine
University of Barcelona, Barcelona, Spain
MPH, Postdoctoral Fellowship
Johns Hopkins University, Baltimore, MD
Executive Forum
Harvard Business School, Boston, MA
Susana Perez-Gutthann has over 3 decades of experience in the research-driven international pharmaceutical environment developing and leading teams of epidemiologists and biostatisticians and driving strategy and research programs for safety, pharmacovigilance, risk management, development, real-world evidence, and regulatory activities applying public health and epidemiologic methods. She is an active leader and past president of the International Society of Pharmacoepidemiology (ISPE) and past vice chair of the Steering Committee of the European Medicines Agency European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). She is a fellow of ISPE and of the Royal College of Physicians, Edinburgh and is invited to teach in academic programs (the London School of Hygiene and Public Health, Oxford University, and University of North Carolina at Chapel Hill) and to speak and chair conferences and symposia. Dr. Perez-Gutthann’s roles as an advisor and in international working groups have included ENCePP research guidance, International Scientific Advisory Board to the Medicines and Healthcare Products Regulatory Agency General Practice Research Database, ISPE Working Groups on Risk Management Guidances (Food and Drug Administration, European Medicines Agency), Good Pharmacoepidemiology Practice, and confidentiality of patient databases in Europe. Currently, Dr. Perez-Gutthann serves as a member and chair of several scientific advisory boards for studies, research programs, strategic and regulatory risk management, and real-world evidence topics. Her prior positions include global head of epidemiology at Pharmacia, Novartis, and Ciba-Geigy; European Head of Epidemiology at Pfizer; and postdoctoral fellow in the Division of Clinical Epidemiology at Johns Hopkins.